Free Trial
OTCMKTS:IMUC

EOM Pharmaceuticals (IMUC) Stock Price, News & Analysis

EOM Pharmaceuticals logo
$0.20 0.00 (0.00%)
(As of 11/20/2024 ET)

About EOM Pharmaceuticals Stock (OTCMKTS:IMUC)

Key Stats

Today's Range
$0.15
$0.20
50-Day Range
$0.08
$0.20
52-Week Range
$0.07
$0.40
Volume
2,103 shs
Average Volume
1,344 shs
Market Capitalization
$23.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.

Receive IMUC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EOM Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMUC Stock News Headlines

ImmunoCellular Therapeutics, Ltd. (IMUC)
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
EOM Pharmaceutical Holdings Inc.
Oramed Pharmaceuticals Inc ORMP
See More Headlines

IMUC Stock Analysis - Frequently Asked Questions

EOM Pharmaceuticals' stock was trading at $0.2320 at the beginning of 2024. Since then, IMUC shares have decreased by 13.8% and is now trading at $0.20.
View the best growth stocks for 2024 here
.

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) posted its earnings results on Monday, August, 13th. The company reported ($0.01) EPS for the quarter.

Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that EOM Pharmaceuticals investors own include Argos Therapeutics (ARGSQ), Nightfood (NGTF), Meta Platforms (META), LadRx (CYTR), Inovio Pharmaceuticals (INO), MannKind (MNKD) and Agenus (AGEN).

Company Calendar

Last Earnings
8/13/2018
Today
11/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IMUC
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
112,245,000
Market Cap
$23.21 million
Optionable
Not Optionable
Beta
0.32
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:IMUC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners